News & Articles

Partnership combines Twist’s leadership in DNA synthesis and synthetic biology with Neogene’s expertise in personalized engineered T cell therapies

Summa Equity Fund II acquires a majority stake in Sengenics, a functional proteomics company with a unique technology for production of full-length, correctly folded and functional proteins

Antibodies available are specific for S1, S2 and receptor-binding domain regions of SARS-CoV-2 Spike protein

The CleanPlex ACE2 & TMPRSS2 Panel assesses differences in patients’ genetic susceptibility to COVID-19 infection and to developing severe disease

Find out how to rapidly test for multiple disease-causing microorganisms with syndromic panel-based testing

Join us on Monday, October 26, to learn about the role serology plays in the clinician toolbox for managing COVID-19

The DeNovix CellDrop™ Automated Cell Counter has been awarded the Gold Seal of Quality based on outstanding scientist reviews

EpiMOGRIFY supports the development of scalable off-the-shelf cell therapies for diseases with a high unmet clinical need

New product is designed to protect consumers with the latest in food testing technology

Explore exclusive interviews, new methods, and free download to help optimize your 3D cell culture

Join us on Tuesday, October 27, to learn more about how SIFT-MS works, how it speeds up analysis, and how it can be validated successfully in accordance with ICH Q2(R1) Guidelines

Join us on Wednesday, October 28, to learn how SpyTag-SpyCatcher technology enables site-directed conjugation and rapid assembly of different antibody format

Combination test for COVID-19, flu and other common respiratory illnesses helps health care professionals prepare for flu season

For their prize, Dr. Lieberman and her team have chosen to receive the upcoming low volume model, the microPro 25

The Phase II clinical trial, which will use cutting-edge CRISPR genetic engineering, has already begun enrolling patients

Streamlined solution features quality control reagent kits, robotic sample preparation, mass spectrometry analysis and data reporting software to transform analysis efficiency

The addition of COVID-19 antibody tests to the portfolio aims to further support the pandemic response on multiple fronts

We reveal the cell counters, LC systems and particle size analyzer that have earned one of these coveted awards based on exceptional reviewer feedback

Learn how high-throughput, real-time cell analysis can accurately detect and quantify virus-neutralizing antibodies and see how this technology is advancing COVID-19 research